Prednisone Completed Phase 1 Trials for Non-Hodgkin's Lymphoma (NHL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00323323CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas
NCT00825149A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma